Global Thalassemia Treatment Market Report By Type (Alpha Thalassemia And Beta Thalassemia), Class (Iron Chelating Drugs And Gene Therapy) End-User (Hospital, Research Institute, Laboratories And Clinics) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210914
May 2019
Report Formats:

As per this study the Global Thalassemia Treatment Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.
 
Thalassemia is the genetic blood disease that affects the production of red blood cells (RBCs) and hemoglobin. It can be characterized by pale skin, headache, fatigue, leg cramp, and rapid heartbeats. Thalassemia can be treated by frequent blood transfusion, iron chelation, stem cell transplant, nutritional supplements, and gene therapy.
 
Market Dynamics
 
Rising occurrence of thalassemia with growing awareness to treat thalassemia is driving the market growth. The rise in healthcare expenditure with the growing popularity of gene therapy is further expected to support market growth in the forecast period. Further, rising clinical trails for the development of novel therapies is expected to upsurge the growth of thalassemia treatment market. However, the high cost of the treatment may act as a challenge to market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of thalassemia treatment.
 
Market Segmentation
 
The broad thalassemia treatment market has been sub-grouped into type, class and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

  • Alpha Thalassemia
  • Beta Thalassemia
 
By Class
  • Iron Chelating Drugs
  • Gene Therapy
 
By End-User
  • Hospital
  • Research Institute
  • Laboratories
  • Clinics
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for thalassemia treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Thalassemia Treatment Market By Revenue (USD MN)
 
Europe Thalassemia Treatment Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the thalassemia treatment market include Acceleron Pharma, Inc., Bluebird Bio, Inc., GlaxoSmithKline plc., Incyte Corporation, IONIS Pharmaceuticals, Kiadis Pharma, La Jolla Pharmaceutical Company, Lonza Group Ltd. and Sangamo Bioscience among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Thalassemia Treatment
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Thalassemia Treatment Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. THALASSEMIA TREATMENT MARKET ANALYSIS BY TYPE
  • Market In Alpha Thalassemia
  • Market In Beta Thalassemia
 
5. THALASSEMIA TREATMENT MARKET ANALYSIS BY CLASS
  • Market In Iron Chelating Drugs
  • Market In Gene Therapy
 
6. THALASSEMIA TREATMENT MARKET ANALYSIS BY END-USER
  • Market In Hospital
  • Market In Research Institute
  • Market In Laboratories
  • Market In Clinics
 
7. THALASSEMIA TREATMENT MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
8. COMPETITIVE LANDSCAPE OF THE THALASSEMIA TREATMENT COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
9. COMPANY PROFILES OF THE THALASSEMIA TREATMENT INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Acceleron Pharma, Inc.
  • Bluebird Bio, Inc.
  • GlaxoSmithKline plc.
  • Incyte Corporation
  • IONIS Pharmaceuticals
  • Kiadis Pharma
  • La Jolla Pharmaceutical Company
  • Lonza Group Ltd.
  • Sangamo Bioscience
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Thalassemia Treatment
Table 2.  Global Thalassemia Treatment Market By Type
Table 3.  Global Thalassemia Treatment Market By Class
Table 4.  Global Thalassemia Treatment Market By End-User
Table 5.  Global Thalassemia Treatment Market By Geography
Table 6.  North America Thalassemia Treatment Market
Table 7.  Europe Thalassemia Treatment Market
Table 8.  Asia Pacific Thalassemia Treatment Market
Table 9.  Latin America Thalassemia Treatment Market
Table 10. Middle East And Africa Thalassemia Treatment Market 
Table 11. Partnership/Collaboration/Agreements
Table 12. Mergers And Acquisitions
Table 13. New Product Development
Table 14. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Thalassemia Treatment Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Thalassemia Treatment
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Thalassemia Treatment Market By Type
Fig. 8.     Global Thalassemia Treatment Market By Class
Fig. 9.     Global Thalassemia Treatment Market By End-User
Fig. 10.   Global Thalassemia Treatment Market By Geography
Fig. 11.   North America Thalassemia Treatment Market
Fig. 12.   Europe Thalassemia Treatment Market
Fig. 13.   Asia Pacific Thalassemia Treatment Market
Fig. 14.   Latin America Thalassemia Treatment Market
Fig. 15.   Middle East And Africa Thalassemia Treatment Market
Fig. 16.   Market Share Of Thalassemia Treatment Companies
Fig. 17.   Recent Developments In Thalassemia Treatment Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC. 

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials